My PCR
Create Account
Logo PCR

19 Dec 2019

Tricuspid / Pulmonary valveTAVIMitral valve replacement and repair

Shaping the future of transcatheter valve interventions

Sponsored by Abbott

Chairpersons: N. Dumonteil, F. Kreidel
Panellists: M. Al Otaiby, Z. Ghazzal, S. Samargandy
SHOW MORE

Summary

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Learning Objectives

  • To learn about tricuspid regurgitation and transcatheter therapies
  • To understand how innovations drive improvement in TAVI procedural and clinical outcomes
  • To review the Tendyne clinical programme and learn of a new therapy in high surgical risk patients in whom good repair results are unlikely

Presentations available when logged in:

  • Why should we treat tricuspid regurgitation using a transcatheter approach?
  • Mitraclip in functional mitral regurgitation and patient selection
  • Tendyne, a new transcatheter treatment option that eliminates mitral regurgitation - Clinical programme update
Related Content
How to approach the challenges of large annuli in TAVI Mitral interventions: translating the new guidelines into practice Step-by-step TAVI procedure in Europe and India - A review from PCR and India Valves
Recommended for you
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025 PCR Rio Valves 2025: Discover what’s in store for this new initiative What's the best way to reduce the cost of your #AictPCR badge?